Stay up to date with our newsletter

Get in touch!

To explore career opportunities with Sai Life Sciences, share your CV here.

Lets start the conversation!

Sign up to our newsletter

Thank you!
We will be in touch shortly.

2019.12.12

Sai Life Sciences announces Sai Nxt, an initiative to transform the organization into a new generation CDMO

Sai Nxt

Sai Life Sciences, one of India’s fastest growing Contract Development & Manufacturing Organizations (CDMOs), today announced Sai Nxt, an organization-wide initiative aimed at transforming the company into a new generation CDMO. Guided by the insights and feedback from its customers, the company is investing upwards of US $ 150 million over the period between 2019 and 2023 as a part of Sai Nxt, with a focus on three key areas :

  1. People & culture
  2. Processes & automation
  3. Infrastructure & scientific capabilities

Making the announcement, Krishna Kanumuri, CEO & Managing Director of Sai Life Sciences said, “Sai Nxt marks a transformative phase in our journey. Our growth over the years has essentially been driven by our scientific capabilities and customer focus. Raising the bar further, Sai Nxt will help us better serve the growing demand from global innovator pharma and biotech companies for speed and flexibility, with an assurance of compliance and dependability.”

Built on the foundation of partnership, Sai Life Sciences has grown to become one of India’s most trusted CDMOs. Coinciding with the completion of 20 years since its inception, Sai Nxt is the transformative lever aimed to propel the organization in the next phase of its growth.

Sai Nxt initiatives

  1. People & Culture: Expanding scientific talent pool, inducting top-notch global scientific and leadership talent, role-based integrated online training, shop floor transformation, nurturing culture of excellence
  2. Processes & Automation: Process simplification, strengthening governance systems, electronic manufacturing records, IT systems integration, foundation for seamless data capture across operations, leveraging latest technologies (RPA, IOT, AI / ML, AR/ VR) for innovation and intelligence
  3. Infrastructure & Capabilities: Biology lab in Cambridge (MA, USA), Process R&D lab in Manchester (UK), Integrated Discovery and Development campus, expanded suite of technology platforms, early phase delivery facility, flexible manufacturing with 2.5x capacity, advanced safety & quality systems

Through Sai Nxt, the company aims to significantly expand and upgrade its R&D and manufacturing facilities, deepen scientific & technological capabilities, strengthen automation and data systems, and above all raise the bar for safety, quality and customer focus.

Share article

News

2021.09.14

Sai Life Sciences achieves EcoVadis Silver for Sustainability

Sai Life Sciences achieves EcoVadis Silver for Sustainability

In a global assessment acknowledged as a gold standard by procurers and suppliers, winning a silver is gratifying. With a net score of 57, nine points higher than last year, Sai Life Sciences has reaffirmed its commitment to social, economic and environmental responsibility in the evaluation by EcoVadis, the world’s most trusted provider of business […]
Read more

2021.09.02

Sai Life Sciences’ API Manufacturing unit

Sai Life Sciences’ API Manufacturing unit receives ‘CII Excellent Energy Efficient Unit’ award

Sai Life Sciences, a global CRO & CDMO offering sustainable solutions to pharmaceutical companies through strategic partnerships and integrated drug discovery and development services, has been awarded with ‘Excellent Energy Efficient Unit’ in the general category at CII’s 22nd National Energy Management Awards. This is the second consecutive year that Sai Life Sciences’ Bidar API […]
Read more

2021.09.01

GSK Environmental Sustainability Supplier Award 2021

Sai Life Sciences wins GSK’s Environmental Sustainability Supplier award 2021 in the ‘Primary Manufacturing’ category

Every year, GlaxoSmithKline (GSK) organises the Environmental Supplier awards to recognise its suppliers’ contribution to environmental sustainability. Now in its 8th year, the platform has grown to become a prestigious forum for recognising superior environmental sustainability practices across the company’s global value chain, with growing participation from several of its direct and indirect suppliers. At […]
Read more

2021.08.26

Sai Life Sciences becomes a signatory of the United Nations Global Compact (UNGC)

Sai Life Sciences becomes a signatory of the United Nations Global Compact (UNGC)

Sai Life Sciences, a leading global Contract Research, Development & Manufacturing Organization (CRO/ CDMO), today announced that it has become a signatory of the United Nations Global Compact (UNGC), the world’s largest sustainability initiative. As a signatory, Sai Life Sciences has committed itself to adopting the Ten Principles of the UNGC on human rights, labour, […]
Read more

2021.08.20

Sai Life Sciences wins Gold at the Brandon Hall Group Excellence Awards 2021

Sai Life Sciences wins Gold at the Brandon Hall Group Excellence Awards 2021

Sai Life Sciences won the Gold Award in Brandon Hall Group Excellence Awards under the “Best Advance in Learning Technology Implementation” category. Standing tall amongst leading global companies like Pfizer, Abbvie, Boehringer, Merck, Takeda, and others, Sai Life Sciences was honored with this award for its consistent innovation in developing the industry’s best learning management […]
Read more